Elena Georgiou et al. reported on gene therapy for CMT4C using an adeno-associated viral 9 vector (AAV9) to deliver the human SH3TC2 gene in the Sh3tc2−/− mouse model. Here, SH3TC2 is linked to Charcot-Marie-Tooth disease type 4C.